DK1088818T3 - Quinolin-4-yl-derivater - Google Patents
Quinolin-4-yl-derivaterInfo
- Publication number
- DK1088818T3 DK1088818T3 DK00120890T DK00120890T DK1088818T3 DK 1088818 T3 DK1088818 T3 DK 1088818T3 DK 00120890 T DK00120890 T DK 00120890T DK 00120890 T DK00120890 T DK 00120890T DK 1088818 T3 DK1088818 T3 DK 1088818T3
- Authority
- DK
- Denmark
- Prior art keywords
- quinolin
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99119539 | 1999-10-01 | ||
EP00120890A EP1088818B1 (en) | 1999-10-01 | 2000-09-26 | Quinolin-4-yl derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1088818T3 true DK1088818T3 (da) | 2005-03-14 |
Family
ID=26071436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00120890T DK1088818T3 (da) | 1999-10-01 | 2000-09-26 | Quinolin-4-yl-derivater |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1088818B1 (da) |
DK (1) | DK1088818T3 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6951875B2 (en) | 2001-10-29 | 2005-10-04 | Hoffmann-La Roche Inc. | Conjugated aromatic compounds with a pyridine substituent |
US6831087B2 (en) | 2001-11-09 | 2004-12-14 | Hoffmann-La Roche Inc. | Pyridine substituted isoquinoline derivatives |
RU2285693C2 (ru) * | 2002-02-13 | 2006-10-20 | Ф.Хоффманн-Ля Рош Аг | Производные пиридина и хинолина, способ их получения, фармацевтическая композиция, применение соединений для лечения заболеваний, ассоциированных с dpp-iv |
NZ546477A (en) * | 2006-04-07 | 2009-04-30 | Auckland Uniservices Ltd | 4-Alkylamino-2-(heterocyclic)quinazolines and their use in cancer therapy |
ES2332857B2 (es) * | 2008-04-22 | 2010-06-24 | Universidad De La Laguna | Betabloqueante fluorescente (+/-) rctm-3 de los receptores adrenergicos de tipo beta. |
US8198300B2 (en) * | 2010-04-29 | 2012-06-12 | Universidad De Chile | Method for preventing tau protein aggregation and treating Alzheimer's disease with a quinoline derivative compound |
ES2769648T3 (es) | 2014-06-16 | 2020-06-26 | Fundacion Para La Investig Medica Aplicada | Nuevos compuestos como inhibidores duales de histona metiltransferasas y ADN metiltransferasasASAS |
JP2022544700A (ja) * | 2019-08-22 | 2022-10-20 | バイオヘイブン・セラピューティクス・リミテッド | 筋萎縮性側索硬化症および関連障害の治療のためにtdp-43に結合する分子 |
TW202408501A (zh) * | 2022-04-22 | 2024-03-01 | 美商維泰克斯製藥公司 | 用於治療疼痛之雜芳基化合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9125515D0 (en) * | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
US5441963A (en) * | 1991-12-20 | 1995-08-15 | Merrell Dow Pharmaceuticals | Potentiation of NMDA antagonists |
-
2000
- 2000-09-26 EP EP00120890A patent/EP1088818B1/en not_active Expired - Lifetime
- 2000-09-26 DK DK00120890T patent/DK1088818T3/da active
Also Published As
Publication number | Publication date |
---|---|
EP1088818A1 (en) | 2001-04-04 |
EP1088818B1 (en) | 2004-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS5381A (is) | 4-fenyl-pyridin afleiður | |
NO20021077L (no) | Amino-triazolopyridin-derivater | |
DE60009747D1 (de) | Admantan-derivate | |
ATE293104T1 (de) | Thiazolylamid-derivate | |
IS6128A (is) | 13-Metýl-erýþrómýsín afleiður | |
DK1187814T3 (da) | 5-phenyl-pyrimidinderivater | |
NO20021803D0 (no) | Isoksazolkarboksamid-derivater | |
ATE257148T1 (de) | Propargyletherderivate | |
DK1154988T3 (da) | Mevinolinderivater | |
ATE374747T1 (de) | Monofluoralkylderivate | |
DK1218340T3 (da) | 4-hydroxybiphenylhydrazid-derivater | |
DK1187815T3 (da) | 4-phenyl-pyrimidinderivater | |
ATE293592T1 (de) | Resorcinderivate | |
NO20005031D0 (no) | Kinolin-4-yl-derivater II | |
DE60015471D1 (de) | Chinolin-4-yl-derivate | |
DK1088818T3 (da) | Quinolin-4-yl-derivater | |
NO20022867D0 (no) | Syklopentenon-derivater | |
NO20020212D0 (no) | 3-amino-2-benzyl-1-fenyl-propanderivater | |
PT1194401E (pt) | Derivados de diacil-hidrazina | |
DE60025348D1 (de) | Ethansulfonyl-piperidin-derivate | |
DE60001736D1 (de) | 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate | |
DE59909774D1 (de) | 1-cycloalkylpyrazolyl-benzoyl-derivate |